BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15298636)

  • 1. Identifying response to acid suppressive therapy in functional dyspepsia using a random starting day trial--is gastro-oesophageal reflux important?
    Madsen LG; Wallin L; Bytzer P
    Aliment Pharmacol Ther; 2004 Aug; 20(4):423-30. PubMed ID: 15298636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducibility of a symptom response to omeprazole therapy in functional dyspepsia evaluated by a random-starting-day trial design.
    Madsen LG; Bytzer P
    Aliment Pharmacol Ther; 2004 Aug; 20(3):365-72. PubMed ID: 15274674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic response to blocked and unblocked pentagastrin stimulation in functional dyspepsia. Comparison of responders and non-responders to omeprazole identified in a single-subject trial model.
    Madsen LG; Bytzer P
    Dig Dis; 2008; 26(3):237-42. PubMed ID: 18463442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
    Bautista J; Fullerton H; Briseno M; Cui H; Fass R
    Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
    Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying responders to acid suppression in dyspepsia using a random starting day trial.
    Bytzer P; Hansen JM; Rune S; Bonnevie O; Breinstrup H; Funch-Jensen P; Matzen P; Meineche-Schmidt V; Schaffalitzky De Muckadell OB
    Aliment Pharmacol Ther; 2000 Nov; 14(11):1485-94. PubMed ID: 11069320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asthma and gastro-oesophageal reflux: can the response to anti-reflux therapy be predicted?
    Kiljander T; Salomaa ER; Hietanen E; Helenius H; Liippo K; Terho EO
    Respir Med; 2001 May; 95(5):387-92. PubMed ID: 11392580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
    Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
    Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern.
    Farup PG; Hovde O; Torp R; Wetterhus S
    Scand J Gastroenterol; 1999 Jun; 34(6):575-9. PubMed ID: 10440606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of oesophageal 24-h ambulatory pH monitoring in patients with functional dyspepsia.
    Gerson LB; Triadafilopoulos G
    Dig Liver Dis; 2005 Feb; 37(2):87-91. PubMed ID: 15733519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
    Peura DA; Kovacs TO; Metz DC; Siepman N; Pilmer BL; Talley NJ
    Am J Med; 2004 Jun; 116(11):740-8. PubMed ID: 15144910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between oesophageal acid exposure and dyspeptic symptoms in patients with nonerosive reflux disease.
    Sarnelli G; De Giorgi F; Efficie E; Aprea G; Masone S; Savarese MF; Esposito I; Russo L; Cuomo R
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):264-8. PubMed ID: 18334868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux.
    Omari TI; Haslam RR; Lundborg P; Davidson GP
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):41-4. PubMed ID: 17204951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease.
    Størdal K; Johannesdottir GB; Bentsen BS; Knudsen PK; Carlsen KC; Closs O; Handeland M; Holm HK; Sandvik L
    Arch Dis Child; 2005 Sep; 90(9):956-60. PubMed ID: 16113133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which dyspepsia patients will benefit from omeprazole treatment? Analysis of a Danish multicenter trial.
    Meineche-Schmidt V; Christensen E
    Am J Gastroenterol; 2000 Oct; 95(10):2777-83. PubMed ID: 11051347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome.
    Harding SM; Richter JE; Guzzo MR; Schan CA; Alexander RW; Bradley LA
    Am J Med; 1996 Apr; 100(4):395-405. PubMed ID: 8610725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term acid suppression by omeprazole in gastro-oesophageal reflux disease patients does not lead to anti-gastric autoantibody production.
    Bergman MP; Klinkenberg-Knol EC; Faller G; Aar A; Lakhai W; Vandenbroucke-Grauls CM; Kuipers EJ; Appelmelk BJ
    Aliment Pharmacol Ther; 2005 Apr; 21(8):977-83. PubMed ID: 15813833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia.
    Vakil N; Talley NJ; Stolte M; Sundin M; Junghard O; Bolling-Sternevald E
    Aliment Pharmacol Ther; 2006 Jul; 24(1):55-63. PubMed ID: 16803603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Look--but also listen! ReQuest: an essay on a new validated scale to assess the outcome of GERD treatment.
    Bardhan KD; Berghöfer P
    Digestion; 2007; 75 Suppl 1():87-100. PubMed ID: 17489037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.